BRIEF published on 04/24/2025 at 14:05, 7 months 11 days ago Pentixapharm signe un accord de fabrication pour la thérapie à l'yttrium-90 Eckert & Ziegler Essais Cliniques Produits Radiopharmaceutiques Pentixapharm Yttrium-90
BRIEF published on 04/24/2025 at 14:05, 7 months 11 days ago Pentixapharm Signs Manufacturing Deal for Yttrium-90 Therapy Clinical Trials Eckert & Ziegler Radiopharmaceuticals Pentixapharm Yttrium-90
PRESS RELEASE published on 04/24/2025 at 14:00, 7 months 11 days ago Pentixapharm Signs Contract Manufacturing Agreement for Yttrium-90-based PentixaTher with Eckert & Ziegler SE Pentixapharm signs manufacturing agreement for Yttrium-90-based PentixaTher with Eckert & Ziegler SE to produce CXCR4-targeting radiotherapeutic doses for clinical trials Clinical Trials Eckert & Ziegler SE Pentixapharm Y90-PentixaTher Radiotherapeutic
BRIEF published on 04/15/2025 at 08:22, 7 months 20 days ago Pentixapharm Holding AG Reports 2024 Financial Results and 2025 Outlook Research And Development Financial Results 2024 2025 Financial Forecast Radiopharmaceutical Innovation Pentixapharm Strategy
BRIEF published on 04/15/2025 at 08:22, 7 months 20 days ago Pentixapharm Holding AG publie ses résultats financiers pour 2024 et ses perspectives pour 2025 Recherche Et Développement Résultats Financiers 2024 Prévisions Financières 2025 Innovation Radiopharmaceutique Stratégie Pentixapharm
PRESS RELEASE published on 04/15/2025 at 08:17, 7 months 20 days ago Pentixapharm Holding AG Releases Financial Results for 2024 and Announces Guidance for the 2025 Financial Year Pentixapharm Holding AG releases 2024 financial results with EUR 12.8 million net loss and guides for EUR 23.5 million loss in 2025, focusing on R&D and operating expenses Financial Results 2024 Net Loss 2025 Pentixapharm
BRIEF published on 03/03/2025 at 14:43, 9 months 2 days ago Pentixapharm Holding AG Announces Board Changes Supervisory Board Board Changes Leadership Transition Pentixapharm Governance Dr. Andreas Eckert
BRIEF published on 03/03/2025 at 14:43, 9 months 2 days ago Pentixapharm Holding AG annonce des changements au sein de son conseil d'administration Conseil De Surveillance Transition De Direction Changements Au Sein Du Conseil D'administration Dr. Andreas Eckert Gouvernance De Pentixapharm
PRESS RELEASE published on 03/03/2025 at 14:38, 9 months 2 days ago Changes in the Supervisory Board and Management Board of Pentixapharm Holding AG Personnel changes in both the Supervisory Board and Management Board of Pentixapharm Holding AG have been implemented as of March 1, 2025, aligning the boards of the parent and subsidiary companies Supervisory Board Management Board Berlin Personnel Changes Pentixapharm Holding AG
BRIEF published on 02/13/2025 at 14:15, 9 months 20 days ago Pentixapharm to Present Pioneering Bladder Cancer Treatment at ASCO-GU 2025 Bladder Cancer Lu177-PentixaTher CXCR4 Target ASCO-GU 2025 Radioligand Therapy
Published on 12/05/2025 at 18:20, 4 minutes ago NuRAN Announces Intention to Complete Consolidation in Preparation to the Restructuring Transaction
Published on 12/05/2025 at 18:00, 24 minutes ago SMX: A New Supply Chain Reality in the World's Four Largest Markets
Published on 12/05/2025 at 17:15, 1 hour 9 minutes ago TRX GOLD Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 17:00, 1 hour 24 minutes ago Three Trillion-Dollar Frontiers, One Technology: How SMX Is Everywhere at Once
Published on 12/05/2025 at 16:00, 2 hours 24 minutes ago SMX Didn't Change Its Story; The World Finally Connected the Dots
Published on 12/05/2025 at 18:15, 9 minutes ago Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:46, 38 minutes ago Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds
Published on 12/05/2025 at 17:00, 1 hour 24 minutes ago EQS-Adhoc: The NAGA Group AG adjusts guidance for financial year 2025 following continued low volatility and weaker year-end performance
Published on 12/05/2025 at 16:25, 1 hour 59 minutes ago 4YFN26 Awards: Meet the Top 20 startups building the future
Published on 12/05/2025 at 17:18, 1 hour 6 minutes ago La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 1 hour 6 minutes ago The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 3 hours 13 minutes ago Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 3 hours 13 minutes ago Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 4 hours 26 minutes ago RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
